Collection: Antimicrobial Resistance
Antibiotic Stewardship: A Collective Responsibility to Combat Antimicrobial Resistance
The global overuse of antibiotics has ignited a silent but formidable threat—antimicrobial resistance (AMR). Once powerful drugs are gradually losing their efficacy, leaving us vulnerable to infections that were once easily treatable. Imagine a future where a minor cut or a simple sore throat could turn fatal if bacteria have become resistant to all available treatments. The tragedy is that antibiotics, which should be reserved for bacterial infections, are often misused, partly because it’s difficult to distinguish bacterial infections from viral ones.
This is where diagnostic tools like CRP and CRP/MxA testing are crucial. By measuring C-reactive protein (CRP) levels and myxovirus resistance protein A (MxA), these tests help healthcare providers quickly determine if an infection is bacterial or viral. This clarity enables targeted antibiotic prescriptions, limiting misuse and helping combat the rise of AMR. As an Antibiotic Guardian, BHR Biosynex is committed to raising awareness of AMR among our colleagues and customers, emphasising that responsible antibiotic use is a collective responsibility—one that protects our future health.
